• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,285.07 521.16
( 0.67%)
Global Indices
Nasdaq
52,921.07 594.83
(1.14%)
Dow Jones
7,504.24 0.01
(0.00%)
Hang Seng
69,576.15 -167.92
(-0.24%)
Nikkei 225
10,649.07 -29.96
(-0.28%)
Forex
USD-INR
95.28 0.28
(0.30%)
EUR-INR
108.75 0.54
(0.50%)
GBP-INR
126.99 1.06
(0.84%)
JPY-INR
0.59 0.01
(0.97%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
377.9559391
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
37.46
114730.36
EPS(TTM)
Face Value()
Div & Yield %
36.69
1
0.58
 

novartis india ltd
Mahamaya Steel Industries consolidated net profit declines 24.77% in the March 2026 quarter
May 26,2026
Net profit of Mahamaya Steel Industries declined 24.77% to Rs 4.07 crore in the quarter ended March 2026 as against Rs 5.41 crore during the previous quarter ended March 2025. Sales rose 11.41% to Rs 263.12 crore in the quarter ended March 2026 as against Rs 236.17 crore during the previous quarter ended March 2025.

For the full year,net profit rose 26.32% to Rs 9.60 crore in the year ended March 2026 as against Rs 7.60 crore during the previous year ended March 2025. Sales rose 10.11% to Rs 882.85 crore in the year ended March 2026 as against Rs 801.76 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales263.12236.17 11 882.85801.76 10
OPM %2.983.27 -2.682.33 -
PBDT7.938.88 -11 21.0817.47 21
PBT5.676.86 -17 12.279.60 28
NP4.075.41 -25 9.607.60 26